Prospect News: News for Cidron Aida Finco Sarl

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with C > Issuers starting with C, BK only > All stories on Cidron Aida Finco Sarl > Stories on Cidron Aida Finco Sarl, BK only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Cidron Aida Finco Sarl

3/28/2025	BKHY	S&P gives AdvanzPharma notes B-
3/26/2025	BK	Advanz Pharma launches €100 million add-on term loan at 99.5 OID
11/6/2024	BKHY	Fitch rates Cidron loan B+
10/17/2024	BK	Advanz Pharma flexes €725 million term loan to Euribor plus 425 bps
10/9/2024	BK	Advanz Pharma launches €725 million term loan at Euribor plus 450 bps
10/8/2024	BK	Advanz Pharma to launch €725 million term loan B on Wednesday
7/29/2024	BK	Moody's changes Advanz view to stable
3/19/2021	BKHY	Moody's assigns Cidron Aida notes B3
3/17/2021	BKHY	Moody's assigns Cidron Aida B3
3/17/2021	BKHY	Fitch assigns Cidron B

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.